G&S Capital’s Merck MRK Stock Holding History

G&S Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$941K	Sell	7,326 -1	-0%	-$117	0.27%	92
2026 Q1	$881K	Sell	7,327 -159	-2%	-$18.4K	0.31%	85
2025 Q4	$788K	Sell	7,486 -135	-2%	-$12.7K	0.28%	88
2025 Q3	$640K	Sell	7,621 -53	-0.7%	-$4.37K	0.24%	98
2025 Q2	$608K	Buy	7,674 +512	+7%	+$40.7K	0.24%	98
2025 Q1	$643K	Buy	+7,162	New	+$669K	0.27%	86
2024 Q4	–	Sell	-21,405	Closed	-$2.43M	–	129
2024 Q3	$2.43M	Buy	21,405 +545	+3%	+$64.7K	1.02%	36
2024 Q2	$2.67M	Buy	20,860 +10,564	+103%	+$1.36M	1.16%	30
2024 Q1	$1.36M	Buy	+10,296	New	+$1.27M	0.61%	52
2020 Q1	–	Sell	-46,684	Closed	-$4.05M	–	221
2019 Q4	$4.05M	Buy	+46,684	New	+$3.83M	2.29%	15
2019 Q1	–	Sell	-84	Closed	-$6K	–	236
2018 Q4	$6K	Buy	+84	New	+$5.93K	0.01%	176
2018 Q1	–	Sell	-5,554	Closed	-$298K	–	206
2017 Q4	$298K	Buy	+5,554	New	+$308K	0.22%	71

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

G&S Capital's MRK Position: Q2 2026 in Review

G&S Capital reduced its Merck (MRK) stake by 0.01% in Q2 2026, selling an estimated $117 and leaving 7,326 shares worth $941K. The position accounts for 0.27% of the portfolio, ranked #92.

G&S Capital first reported a position in MRK in Q4 2017 and has held it in 12 quarters since. The position peaked at $4.05M in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

G&S Capital held 7,326 shares of Merck worth $941K as of Q2 2026.
G&S Capital sold 1 Merck share in Q2 2026, an estimated $117.
Merck made up 0.27% of G&S Capital's portfolio in Q2 2026, its #92 holding.
G&S Capital first reported a position in Merck in Q4 2017 and has held it in 12 quarters since.
G&S Capital's Merck position peaked at $4.05M in Q4 2019.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.